Key result
Cardiovascular disease prevalence among Europeans aged ≥75 years increased by >87% in men and >45% in women from 1990 to 2021, highlighting the need for individualized, multidisciplinary care.
Why the study?
Population ageing has increased the burden of CVD and associated challenges like multimorbidity and frailty among older adults in Europe, yet their underrepresentation in clinical research limits the evidence available to guide management.
Answers are grounded in this paper and cite their sources.
This narrative review highlights the growing prevalence of cardiovascular disease in ageing European populations and underscores the necessity of greater inclusion of older adults in clinical trials alongside individualized, multidisciplinary care addressing frailty, multimorbidity, and socioeconomic inequalities.
Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among older adults in Europe. Population ageing has increased the burden of cardiovascular conditions and highlighted challenges related to multimorbidity, frailty, cognitive impairment, and inequalities in healthcare access. However, older individuals remain underrepresented in clinical research, limiting the evidence available to guide their management. Aim: This review examines the epidemiology, diagnostic challenges, treatment limitations, and prevention of CVD among older adults in Europe, with particular attention to frailty, rehabilitation, social inequalities, and multidisciplinary healthcare delivery. Methods: A narrative review of the available literature was conducted to discuss demographic trends, cardiovascular risk factors, clinical presentations, diagnostic approaches, pharmacological and invasive treatments, lifestyle interventions, and healthcare-related outcomes in older populations. Results: CVD prevalence and associated healthcare demands increase with advancing age. Underrepresentation in randomized clinical trials limits the applicability of treatment recommendations to older patients. Age-related physiological changes, atypical symptoms, and limitations in cardiovascular risk prediction complicate diagnosis. Multimorbidity, polypharmacy, and cognitive impairment further influence treatment safety and adherence. Evidence regarding invasive cardiovascular interventions in frail older patients remains mixed, supporting individualized treatment decisions. Prevention requires appropriate pharmacological management, nutritional support, smoking cessation, and physical activity. Frailty assessment and cardiac rehabilitation can support functional independence. Socioeconomic disadvantage, geographical barriers, and social isolation further contribute to inequalities in cardiovascular outcomes. Conclusion: Effective cardiovascular care requires an integrated approach that considers biological ageing, functional status, comorbidities, and patient preferences. Greater inclusion of older adults in clinical trials and stronger multidisciplinary services are essential to improve outcomes and reduce inequalities
No takes yet. Share an insight, caveat, or question.
Khard et al. (2026) conducted a review in Cardiovascular disease. Cardiovascular disease prevalence among Europeans aged ≥75 years increased by >87% in men and >45% in women from 1990 to 2021, highlighting the need for individualized, multidisciplinary care.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: